Why is Jenburkt Pharma falling/rising?

As of 10-Nov, Jenburkt Pharmaceuticals Ltd. is experiencing a price increase, currently at 1,268.00, reflecting a rise of 77.3 points or 6.49%. The stock has shown a trend reversal, gaining after three consecutive days of decline. It opened with a gain of 2.18% today and reached an intraday high of Rs 1,317, marking a 10.61% increase. Despite this positive movement, there has been a notable decrease in investor participation, with delivery volume falling by 79.54% compared to the 5-day average. Over the past month, the stock has outperformed the benchmark Sensex, with a return of 17.06% compared to the Sensex's 1.25%. Additionally, the stock is trading above all key moving averages, indicating a strong upward trend.
In the broader market context, while Jenburkt Pharmaceuticals has shown a short-term return of -0.62% over the past week, the Sensex has similarly declined by -0.53%, suggesting that the stock's performance is somewhat aligned with the overall market trend. However, the significant outperformance over the past month and the positive intraday movement indicate that investors may be reacting favorably to recent developments, despite the recent drop in delivery volume. The liquidity of the stock remains adequate for trading, which may also contribute to its current upward momentum.